Megakaryocyte synthesis is the source of epidermal growth factor in human platelets
- PMID: 2221009
- PMCID: PMC1877562
Megakaryocyte synthesis is the source of epidermal growth factor in human platelets
Abstract
Epidermal growth factor (EGF) is known to be present in the alpha granules of human platelets; however the source of this EGF, ie, whether it is taken up by the platelets from the circulation, or whether it is packaged into the platelets from the megakaryocyte during thrombopoiesis, is unknown. To determine whether EGF is taken up by platelets, platelets for EGF receptors were assayed and it was attempted to detect uptake of EGF by the platelets from culture medium. Platelets were found to lack EGF receptors, and no uptake of EGF from the culture medium was detected. To assess whether EGF is packaged into platelets from the megakaryocyte, megakaryocytes in frozen section bone marrow cores were stained for EGF protein by immunohistochemistry, and it was demonstrated that EGF is present in megakaryocytes. In addition, staining of megakaryocytes by in situ hybridization for EGF mRNA demonstrated its presence in these cells. Therefore it is concluded that the source of EGF in human platelets is the megakaryocyte and that this EGF is synthesized in the megakaryocyte rather than being taken up from its environment.
Similar articles
-
Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules.Blood. 1990 Nov 15;76(10):1946-55. Blood. 1990. PMID: 2242422
-
Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets.Endocrinology. 1994 Sep;135(3):929-37. doi: 10.1210/endo.135.3.8070388. Endocrinology. 1994. PMID: 8070388
-
Megakaryocytes endocytose insulin-like growth factor (IGF) I and IGF-binding protein-3: a novel mechanism directing them into alpha granules of platelets.Endocrinology. 1998 Feb;139(2):559-65. doi: 10.1210/endo.139.2.5727. Endocrinology. 1998. PMID: 9449625
-
Megakaryocyte function and dysfunction.Baillieres Clin Haematol. 1989 Jul;2(3):543-68. doi: 10.1016/s0950-3536(89)80033-2. Baillieres Clin Haematol. 1989. PMID: 2673428 Review.
-
Regulation of the genetic code in megakaryocytes and platelets.J Thromb Haemost. 2015 Jun;13 Suppl 1(0 1):S26-32. doi: 10.1111/jth.12965. J Thromb Haemost. 2015. PMID: 26149034 Free PMC article. Review.
Cited by
-
Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations.Cancer Med. 2020 Sep;9(18):6533-6549. doi: 10.1002/cam4.3246. Epub 2020 Jul 25. Cancer Med. 2020. PMID: 32710512 Free PMC article.
-
Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma.Can J Gastroenterol Hepatol. 2018 Jun 27;2018:9142672. doi: 10.1155/2018/9142672. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30050894 Free PMC article. Review.
-
Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.J Immunol. 2018 Oct 1;201(7):2154-2164. doi: 10.4049/jimmunol.1800124. Epub 2018 Aug 27. J Immunol. 2018. PMID: 30150285 Free PMC article.
-
Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF).Front Physiol. 2018 Apr 6;9:337. doi: 10.3389/fphys.2018.00337. eCollection 2018. Front Physiol. 2018. PMID: 29686623 Free PMC article.
-
Differential effects of tumor-platelet interaction in vitro and in vivo in glioblastoma.J Neurooncol. 2011 Oct;105(1):45-56. doi: 10.1007/s11060-011-0560-2. Epub 2011 Mar 8. J Neurooncol. 2011. PMID: 21384216
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources